Industry hits back at Lancet paper for ‘rifling through the bones of an old, musty evidence base’

A review of medicinal cannabis clinical trials which concluded there was “no evidence” for its use in treating a range of conditions has been branded incomplete, lacking in nuance and ignoring the real-life experiences of thousands of patients.

Following another public mauling in the mainstream media, triggered by a paper published in Lancet Psychiatry, the industry hit back, arguing the review merely demonstrated one thing: that more research is needed.